"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sable told CNBC in an ...
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
The IPO consists of fresh issue of shares worth up to 15 billion rupees, while existing shareholder Menon Family Holdings ...
Denta Water IPO opened for subscription on January 22 and will close on January 24. The company aims to raise ₹220.50 crore ...
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...
The issue will open its window for bidding from January 29 to January 31, with the anchor investor bidding set to begin on ...
The company intends to raise Rs 72.30 crore via initial share sale at the upper price band. The book built issue comprises of ...
The initial share sale of Denta Water and Infra Solutions Ltd garnered 221.52 times subscriptions on the closing day of ...
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...